Viewing nowLipinon 80 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 82.88mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 200809402 · Notified 2008.09.10 · Insurance code 642506260
Reduction of the risk of myocardial infarction and stroke, and improvement of hyperlipidemia
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in individuals over 55 years old or those with risk factors such as smoking, hypertension, and low HDL cholesterol levels, and it also reduces the risk of vascular surgeries and chronic stable angina. In patients with type 2 diabetes who have risk factors like retinopathy, albuminuria, smoking, or hypertension, it is effective in reducing the risk of myocardial infarction and stroke. For adult patients previously diagnosed with coronary heart disease, it reduces the risk of non-fatal myocardial infarction and both fatal and non-fatal strokes, and also helps reduce the risk of vascular surgeries, congestive heart failure hospitalizations, and angina. Additionally, it is used in the treatment of hyperlipidemia, contributing to lowering cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while raising HDL cholesterol levels. It is also used as an adjunctive treatment in patients with dyslipidemia or elevated serum triglycerides who do not respond well to dietary therapy and can be used alone or in combination with other therapies for familial hypercholesterolemia to improve cholesterol levels. This medication is effectively used for the treatment of both cardiovascular diseases and hyperlipidemia.
For hyperlipidemia, the recommended initial dose is atorvastatin at 10 mg once daily, but for patients requiring additional LDL cholesterol reduction, treatment may start at 20 mg or 40 mg once daily. This medication is administered in a dose range of 10 to 80 mg once daily. The initial and maintenance doses should be individualized based on treatment goals and responses, and lipid levels should be analyzed and adjusted accordingly 2 to 4 weeks after initiation or dose adjustment.
This medication may lead to unusual symptoms in the muscles, so if symptoms like muscle pain or weakness worsen, or if creatine kinase levels rise significantly, use must be discontinued immediately. This medication should not be used in patients with certain liver diseases or muscle diseases, in pregnant women or women who may become pregnant, in children under 10 years, or in patients taking certain medications. Patients with poor liver function or alcohol dependence should exercise extra caution while using this medication and undergo regular liver function tests. Since this medication can alter blood concentrations when taken with certain drugs, patients must inform their doctor or pharmacist when taking other medications concurrently. If symptoms such as muscle pain, fatigue, or fever develop while taking this medication, medical attention should be sought immediately. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraceptive methods while taking this medication. Elderly patients or those with reduced kidney function are at a higher risk of muscle disease, so extra caution is needed during use, and regular health checks are required. In cases of overdose, there are no specific detoxification methods, and it is important to receive treatment according to symptoms and undergo liver function and muscle-related tests. This medication should be kept out of the reach of children and stored in its original container safely.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, respiratory problems, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.
This medication is a white oval film-coated tablet.
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 82.88mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.